跳至主要内容
临床试验/DRKS00008746
DRKS00008746招募中2 期

Chemical renal denervation for the treatment of resistant hypertension - CRASH

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 100 人开始时间: 2019年6月19日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patient with therapy-resistant type. Hypertonicity (syst. RR> 140 mmHg despite optimized therapy with = 3 antihypertensive drugs of different classes - state of the art over 3 months),
  • Diagnosis of the therapy-resistant type. Hypertension by a specialist in nephrology / high-pressure ambulance takes place incl. Advice on all alternative therapy methods
  • GFR> 45 ml / min / 1.73 m²
  • Pat. With refractory hypertension at Z.n. ineffective catheter-directed RD

排除标准

  • patients with secondary hypertension (e.g., renoparenchymatous hypertension, NAST, primary hyperaldosteronism, pheochromocytoma, sleep apnea syndrome)
  • Stenosing heart valve disease
  • Z.n. Myocardial infarction, unstable angina pectoris, cerebrovascular event within the last 6 months prior to enrollment

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验

Chemical renal denervation for the treatment of... | 临床试验